Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ
Zmień bibliotekę

Wyszukujesz frazę ""Neoplasms"" wg kryterium: Temat


Tytuł :
Characteristics of colorectal neuroendocrine tumors in patients prospectively enrolled in a Japanese multicenter study: a first report from the C-NET STUDY.
Autorzy :
Sekiguchi M; Endoscopy Division, Cancer Screening Center, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan. .
Hotta K; Division of Endoscopy, Shizuoka Cancer Center, Shizuoka, Japan.
Takeuchi Y; Department of Gastrointestinal Oncology, Osaka International Cancer Institute, Osaka, Japan.
Tanaka S; Department of Endoscopy, Hiroshima University Hospital, Hiroshima, Japan.
Yamamoto H; Department of Medicine, Division of Gastroenterology, Jichi Medical University, Tochigi, Japan.
Shinmura K; Department of Gastroenterology and Endoscopy, National Cancer Center Hospital East, Chiba, Japan.
Harada K; Department of Gastroenterology and Hepatology, Okayama University Hospital, Okayama, Japan.
Uraoka T; Department of Gastroenterology and Hepatology, Gunma University Graduate School of Medicine, Gunma, Japan.
Hisabe T; Department of Gastroenterology, Fukuoka University Chikushi Hospital, Fukuoka, Japan.
Sano Y; Gastrointestinal Center, Sano Hospital, Hyogo, Japan.
Kondo H; Department of Gastroenterology, Tonan Hospital, Hokkaido, Japan.
Horimatsu T; Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital, Kyoto, Japan.
Kikuchi H; Department of Gastroenterology and Hematology, Hirosaki University Graduate School of Medicine, Aomori, Japan.
Kawamura T; Department of Gastroenterology, Kyoto Second Red Cross Hospital, Kyoto, Japan.
Nagata S; Department of Gastroenterology, Hiroshima City Asa Citizens Hospital, Hiroshima, Japan.
Yamamoto K; Department of Gastroenterology, JCHO Osaka Hospital, Osaka, Japan.
Tajika M; Department of Endoscopy, Aichi Cancer Center Hospital, Aichi, Japan.
Tsuji S; Department of Gastroenterology, Ishikawa Prefectural Central Hospital, Ishikawa, Japan.
Kusaka T; Department of Gastroenterology and Hepatology, Kyoto Katsura Hospital, Kyoto, Japan.
Okuyama Y; Department of Gastroenterology, Kyoto First Red Cross Hospital, Kyoto, Japan.
Yoshida N; Department of Molecular Gastroenterology and Hepatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Moriyama T; International Medical Department, Kyushu University Hospital, Fukuoka, Japan.
Hasebe A; Department of Gastroenterology, Shikoku Cancer Center, Ehime, Japan.
So S; Department of Gastroenterology, Tobata Kyoritsu Hospital, Fukuoka, Japan.
Kobara H; Department of Gastroenterology and Neurology, Faculty of Medicine, Kagawa University, Kagawa, Japan.
Kashida H; Department of Gastroenterology and Hepatology, Faculty of Medicine, Kindai University, Osaka, Japan.
Miyanaga R; Department of Gastroenterology, National Hospital Organization Tokyo Medical Center, Tokyo, Japan.
Kato S; Department of Gastroenterology, NTT Medical Center, Sapporo, Hokkaido, Japan.
Hayashi Y; Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine, Osaka, Japan.
Sada M; Department of Gastroenterology, Kitasato University Hospital, Kanagawa, Japan.
Fukuzawa M; Department of Gastroenterology and Hepatology, Tokyo Medical University Hospital, Tokyo, Japan.
Kato H; Department of Clinical Laboratory and Endoscopy, Tokyo Women's Medical University Adachi Medical Center, Tokyo, Japan.
Takayama T; Department of Gastroenterology and Oncology, Graduate School of Biomedical Sciences, Tokushima University, Tokushima, Japan.
Konishi J; Department of Gastroenterology, Tochigi Cancer Center, Tochigi, Japan.
Matsushita HO; Digestive Disease Center, Akita Red Cross Hospital, Akita, Japan.
Narasaka T; Division of Endoscopic Center, University of Tsukuba Hospital, Ibaraki, Japan.
Ohata K; Department of Gastrointestinal Endoscopy, NTT Medical Center Tokyo, Tokyo, Japan.
Togashi K; Department of Coloproctology, Aizu Medical Center, Fukushima Medical University, Fukushima, Japan.
Nakamura H; Akasaka Endoscopic Clinic, Tokyo, Japan.
Moriichi K; Gastroenterology and Endoscopy, Division of Metabolism and Biosystemic Science, Gastroenterology, and Hematology/Oncology, Department of Medicine, Asahikawa Medical University, Hokkaido, Japan.
Oda Y; Oda GI Endoscopy and Gastroenterology Clinic, Kumamoto, Japan.
Kanda N; Department of Gastroenterology and Hepatology, Takatsuki Red Cross Hospital, Osaka, Japan.
Kuwai T; Department of Gastroenterology, National Hospital Organization Kure Medical Center and Chugoku Cancer Center, Hiroshima, Japan.
Terai S; Division of Gastroenterology and Hepatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
Sanomura M; Department of Gastroenterology, Hokusetsu General Hospital, Osaka, Japan.
Kitamura S; Department of Gastroenterology, Sakai City Medical Center, Osaka, Japan.
Miyamoto H; Department of Gastroenterology, Hanwasumiyoshi General Hospital, Osaka, Japan.
Kiriyama S; Department of Surgery, Gunma Chuo Hospital, Gunma, Japan.
Mizuno C; Department of Gastroenterology and Hepatology, Saiseikai Suita Hospital, Osaka, Japan.
Saito Y; Endoscopy Division, National Cancer Center Hospital, Tokyo, Japan.
Sekine S; Division of Diagnostic Pathology, National Cancer Center Hospital, Tokyo, Japan.
Ito S; Division of Endoscopy, Shizuoka Cancer Center, Shizuoka, Japan.
Nakahira H; Department of Gastrointestinal Oncology, Osaka International Cancer Institute, Osaka, Japan.
Oka S; Department of Endoscopy, Hiroshima University Hospital, Hiroshima, Japan.
Hayashi Y; Department of Medicine, Division of Gastroenterology, Jichi Medical University, Tochigi, Japan.
Yoshimura K; Department of Biostatistics, Medical Center for Translational and Clinical Research, Hiroshima University Hospital, Hiroshima, Japan.
Ishikawa H; Department of Molecular-Targeting Prevention, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Matsuda T; Endoscopy Division, Cancer Screening Center, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.; Division of Gastroenterology and Hepatology, Toho University Omori Medical Center, Tokyo, Japan.
Pokaż więcej
Corporate Authors :
C-NET STUDY Group
Źródło :
Journal of gastroenterology [J Gastroenterol] 2022 Aug; Vol. 57 (8), pp. 547-558. Date of Electronic Publication: 2022 May 13.
Typ publikacji :
Journal Article; Multicenter Study
MeSH Terms :
Colorectal Neoplasms*/epidemiology
Colorectal Neoplasms*/pathology
Colorectal Neoplasms*/surgery
Neuroendocrine Tumors*/diagnosis
Neuroendocrine Tumors*/surgery
Rectal Neoplasms*/pathology
Humans ; Intestinal Neoplasms ; Japan/epidemiology ; Pancreatic Neoplasms ; Prospective Studies ; Retrospective Studies ; Stomach Neoplasms
SCR Disease Name :
Gastro-enteropancreatic neuroendocrine tumor
Czasopismo naukowe
Tytuł :
Molecular characterization of gastric adenocarcinoma diagnosed in patients previously treated for Hodgkin lymphoma or testicular cancer.
Autorzy :
Rigter LS; Department of Gastroenterology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
Snaebjornsson P; Department of Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
Rosenberg EH; Department of Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
Altena E; Department of Gastroenterology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
van Grieken NCT; Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands.
Aleman BMP; Department of Radiation Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
Kerst JM; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
Morton L; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America.
Schaapveld M; Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
Meijer GA; Department of Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
van Leeuwen FE; Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
van Leerdam ME; Department of Gastroenterology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
Pokaż więcej
Corporate Authors :
PALGA group
Źródło :
PloS one [PLoS One] 2022 Jul 25; Vol. 17 (7), pp. e0270591. Date of Electronic Publication: 2022 Jul 25 (Print Publication: 2022).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Adenocarcinoma*/genetics
Epstein-Barr Virus Infections*
Hodgkin Disease*/genetics
Stomach Neoplasms*/pathology
Testicular Neoplasms*
Brain Neoplasms ; Colorectal Neoplasms ; Herpesvirus 4, Human/genetics ; Humans ; Male ; Microsatellite Instability ; Neoplasms, Germ Cell and Embryonal ; Neoplastic Syndromes, Hereditary
SCR Disease Name :
Testicular Germ Cell Tumor; Turcot syndrome
Czasopismo naukowe
Tytuł :
Flat-based over-the-scope clip-assisted endoscopic full-thickness resection of a duodenal neuroendocrine tumour: a safe alternative to endoscopic submucosal dissection.
Autorzy :
Sonthalia N; Institute of Gastrosciences and Liver diseases, Apollo Gleneagles Hospital, Kolkata, India.
Shah BB; Institute of Gastrosciences and Liver diseases, Apollo Gleneagles Hospital, Kolkata, India.
Goenka MK; Institute of Gastrosciences and Liver diseases, Apollo Gleneagles Hospital, Kolkata, India.
Pokaż więcej
Źródło :
Endoscopy [Endoscopy] 2022 Jul; Vol. 54 (7), pp. E391-E393. Date of Electronic Publication: 2021 Aug 09.
Typ publikacji :
Journal Article
MeSH Terms :
Duodenal Neoplasms*/surgery
Endoscopic Mucosal Resection*
Neuroendocrine Tumors*/surgery
Stomach Neoplasms*/surgery
Humans ; Intestinal Neoplasms ; Pancreatic Neoplasms ; Treatment Outcome
SCR Disease Name :
Gastro-enteropancreatic neuroendocrine tumor
Czasopismo naukowe
Tytuł :
Pathologic fracture in metastatic kidney cancer: Identifying widening disparities and opportunity for quality improvement.
Autorzy :
Bhanvadia RR; Department of Urology, UT Southwestern Medical Center, Dallas, TX.
Baky FJ; Department of Urology, UT Southwestern Medical Center, Dallas, TX.
Ashbrook CQ; Department of Urology, UT Southwestern Medical Center, Dallas, TX. Electronic address: .
Lotan Y; Department of Urology, UT Southwestern Medical Center, Dallas, TX.
Woldu SL; Department of Urology, UT Southwestern Medical Center, Dallas, TX.
Pokaż więcej
Źródło :
Urologic oncology [Urol Oncol] 2022 Aug; Vol. 40 (8), pp. 384.e1-384.e8. Date of Electronic Publication: 2022 May 31.
Typ publikacji :
Journal Article
MeSH Terms :
Bone Neoplasms*/secondary
Carcinoma, Renal Cell*/complications
Carcinoma, Renal Cell*/pathology
Fractures, Spontaneous*/complications
Kidney Neoplasms*/complications
Kidney Neoplasms*/pathology
Hospitalization ; Humans ; Length of Stay ; Male ; Prostatic Neoplasms/complications ; Prostatic Neoplasms/pathology ; Quality Improvement
Czasopismo naukowe
Tytuł :
An Exceptional Response to Dostarlimab in Mismatch Repair Deficient, Microsatellite Instability-High and Platinum Refractory Endometrial Cancer.
Autorzy :
Bartoletti M; Unit of Medical Oncology and Cancer Prevention, Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano (CRO), 33081 Aviano, Italy.
Giorda G; Unit of Gynecologic Oncology Surgery, IRCCS CRO Aviano, National Cancer Institute, 33081 Aviano, Italy.
Viel A; Unit of Functional Oncogenomics and Genetics, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, 33081 Aviano, Italy.
Fornasarig M; Unit of Oncologic Gastroenterology, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, 33081 Aviano, Italy.
Zdjelar A; Department of Oncologic Radiation Therapy and Diagnostic Imaging, Centro di Riferimento Oncologico, Via Franco Gallini, 2, 33081 Aviano, Italy.
Segatto E; Department of Oncologic Radiation Therapy and Diagnostic Imaging, Centro di Riferimento Oncologico, Via Franco Gallini, 2, 33081 Aviano, Italy.
Sorio R; Unit of Medical Oncology and Cancer Prevention, Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano (CRO), 33081 Aviano, Italy.
Corsetti S; Unit of Medical Oncology and Cancer Prevention, Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano (CRO), 33081 Aviano, Italy.
Scalone S; Unit of Medical Oncology and Cancer Prevention, Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano (CRO), 33081 Aviano, Italy.
Nicoloso MS; Unit of Medical Oncology and Cancer Prevention, Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano (CRO), 33081 Aviano, Italy.
Pivetta T; Unit of Medical Oncology and Cancer Prevention, Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano (CRO), 33081 Aviano, Italy.; Department of Medicine, University of Udine, 33100 Udine, Italy.
Lucia E; Unit of Gynecologic Oncology Surgery, IRCCS CRO Aviano, National Cancer Institute, 33081 Aviano, Italy.
Clemente N; Unit of Gynecologic Oncology Surgery, IRCCS CRO Aviano, National Cancer Institute, 33081 Aviano, Italy.
Palazzari E; Radiation Oncology, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, 33081 Aviano, Italy.
Canzonieri V; Pathology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, 33081 Aviano, Italy.; Department of Medical, Surgical and Health Sciences, University of Trieste, 34127 Trieste, Italy.
Puglisi F; Unit of Medical Oncology and Cancer Prevention, Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano (CRO), 33081 Aviano, Italy.; Department of Medicine, University of Udine, 33100 Udine, Italy.
Pokaż więcej
Źródło :
Current oncology (Toronto, Ont.) [Curr Oncol] 2022 Jul 22; Vol. 29 (8), pp. 5209-5212. Date of Electronic Publication: 2022 Jul 22.
Typ publikacji :
Case Reports
MeSH Terms :
Endometrial Neoplasms*/drug therapy
Endometrial Neoplasms*/genetics
Neoplastic Syndromes, Hereditary*
Antibodies, Monoclonal, Humanized ; Brain Neoplasms ; Colorectal Neoplasms ; DNA Mismatch Repair ; Female ; Humans ; Immune Checkpoint Inhibitors ; Microsatellite Instability ; Platinum/therapeutic use ; Programmed Cell Death 1 Receptor
SCR Disease Name :
Turcot syndrome
Raport
Tytuł :
Patterns of Lymph Node Metastasis and Optimal Surgical Strategy in Small (≤20 mm) Gastroenteropancreatic Neuroendocrine Tumors.
Autorzy :
Cai Y; Department of Colorectal Surgery, The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, China.
Liu Z; Department of Colorectal Surgery, The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, China.
Jiang L; Department of Colorectal Surgery, The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, China.
Ma D; Department of Colorectal Surgery, The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, China.
Zhou Z; Department of Colorectal Surgery, The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, China.
Ju H; Department of Colorectal Surgery, The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, China.
Zhu Y; Department of Colorectal Surgery, The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, China.
Pokaż więcej
Źródło :
Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2022 Jul 21; Vol. 13, pp. 871830. Date of Electronic Publication: 2022 Jul 21 (Print Publication: 2022).
Typ publikacji :
Journal Article
MeSH Terms :
Intestinal Neoplasms*/pathology
Intestinal Neoplasms*/surgery
Neuroendocrine Tumors*/pathology
Humans ; Lymphatic Metastasis ; Pancreatic Neoplasms ; Retrospective Studies ; Stomach Neoplasms
SCR Disease Name :
Gastro-enteropancreatic neuroendocrine tumor
Czasopismo naukowe
Tytuł :
Management of type-I gastric neuroendocrine neoplasms: A 10-years prospective single centre study.
Autorzy :
Esposito G; Digestive Disease Unit, Sant'Andrea University Hospital, Sapienza University of Rome, ENETS Center of Excellence, Rome, Italy; Department of Medical-Surgical Sciences and Translational Medicine, Sapienza University of Rome, Rome, Italy.
Cazzato M; Digestive Disease Unit, Sant'Andrea University Hospital, Sapienza University of Rome, ENETS Center of Excellence, Rome, Italy; Department of Medical-Surgical Sciences and Translational Medicine, Sapienza University of Rome, Rome, Italy.
Rinzivillo M; Digestive Disease Unit, Sant'Andrea University Hospital, Sapienza University of Rome, ENETS Center of Excellence, Rome, Italy.
Pilozzi E; Department of Clinical and Molecular Medicine, Sant'Andrea University Hospital, Sapienza University of Rome, ENETS Center of Excellence, Rome, Italy.
Lahner E; Digestive Disease Unit, Sant'Andrea University Hospital, Sapienza University of Rome, ENETS Center of Excellence, Rome, Italy; Department of Medical-Surgical Sciences and Translational Medicine, Sapienza University of Rome, Rome, Italy.
Annibale B; Digestive Disease Unit, Sant'Andrea University Hospital, Sapienza University of Rome, ENETS Center of Excellence, Rome, Italy; Department of Medical-Surgical Sciences and Translational Medicine, Sapienza University of Rome, Rome, Italy.
Panzuto F; Digestive Disease Unit, Sant'Andrea University Hospital, Sapienza University of Rome, ENETS Center of Excellence, Rome, Italy. Electronic address: .
Pokaż więcej
Źródło :
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver [Dig Liver Dis] 2022 Jul; Vol. 54 (7), pp. 890-895. Date of Electronic Publication: 2021 Dec 10.
Typ publikacji :
Journal Article
MeSH Terms :
Colonic Polyps*/pathology
Endoscopic Mucosal Resection*
Stomach Neoplasms*/pathology
Stomach Neoplasms*/surgery
Colonoscopy ; Gastric Mucosa/pathology ; Gastroscopy/methods ; Humans ; Intestinal Neoplasms ; Neoplasm Recurrence, Local/pathology ; Neuroendocrine Tumors ; Pancreatic Neoplasms ; Prospective Studies ; Retrospective Studies ; Treatment Outcome
SCR Disease Name :
Gastro-enteropancreatic neuroendocrine tumor
Czasopismo naukowe
Tytuł :
Double-endoscope assisted endoscopic submucosal dissection for treating gastric neuroendocrine tumor.
Autorzy :
Lu J; School of Medicine, Shandong University, Jinan, Shandong, China.; Department of Gastroenterology, Qilu Hospital, Shandong University, Jinan, Shandong, China.
Wang P; Department of Gastroenterology, Qilu Hospital, Shandong University, Jinan, Shandong, China.
Ji R; Department of Gastroenterology, Qilu Hospital, Shandong University, Jinan, Shandong, China.
Lu X; Department of Gastroenterology, Qilu Hospital, Shandong University, Jinan, Shandong, China.
Pokaż więcej
Źródło :
Endoscopy [Endoscopy] 2022 Jul; Vol. 54 (7), pp. E342-E343. Date of Electronic Publication: 2021 Jul 19.
Typ publikacji :
Journal Article
MeSH Terms :
Endoscopic Mucosal Resection*
Neuroendocrine Tumors*/pathology
Neuroendocrine Tumors*/surgery
Stomach Neoplasms*/pathology
Stomach Neoplasms*/surgery
Endoscopes ; Gastric Mucosa/pathology ; Humans ; Intestinal Neoplasms ; Pancreatic Neoplasms
SCR Disease Name :
Gastro-enteropancreatic neuroendocrine tumor
Czasopismo naukowe
Tytuł :
Evaluating Mismatch Repair Status to Screen Clinical Advanced Breast Carcinomas for Immunotherapy: Experience From a Large Academic Institution.
Autorzy :
Arole V; The Ohio State University Wexner Medical Center, Columbus, OH; Department of Pathology, Wexner Medical Center at The Ohio State University, Columbus, OH.
Shafi S; The Ohio State University Wexner Medical Center, Columbus, OH; Department of Pathology, Wexner Medical Center at The Ohio State University, Columbus, OH.
Challa B; The Ohio State University Wexner Medical Center, Columbus, OH; Department of Pathology, Wexner Medical Center at The Ohio State University, Columbus, OH.
Parwani AV; The Ohio State University Wexner Medical Center, Columbus, OH; Department of Pathology, Wexner Medical Center at The Ohio State University, Columbus, OH.
Tozbikian G; The Ohio State University Wexner Medical Center, Columbus, OH; Department of Pathology, Wexner Medical Center at The Ohio State University, Columbus, OH.
Li Z; The Ohio State University Wexner Medical Center, Columbus, OH; Department of Pathology, Wexner Medical Center at The Ohio State University, Columbus, OH. Electronic address: .
Pokaż więcej
Źródło :
Clinical breast cancer [Clin Breast Cancer] 2022 Jul; Vol. 22 (5), pp. e680-e684. Date of Electronic Publication: 2022 Jan 22.
Typ publikacji :
Journal Article
MeSH Terms :
Breast Neoplasms*/genetics
Breast Neoplasms*/therapy
Neoplastic Syndromes, Hereditary*/genetics
Brain Neoplasms ; Colorectal Neoplasms ; DNA Mismatch Repair/genetics ; Female ; Humans ; Immunotherapy
SCR Disease Name :
Turcot syndrome
Czasopismo naukowe
Tytuł :
Prevalence of Epstein-Barr Virus Infection and Mismatch Repair Protein Deficiency and the Correlation of Immune Markers in Tibetan Patients with Gastric Cancer.
Autorzy :
Shi J; Department of Pathology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Yang X; Department of Liver Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Wang X; Department of Pathology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Luo Y; Department of Pathology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Zhou W; Department of Pathology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Luo H; Department of Pathology, Tibet Autonomous Region People's Hospital, Lhasa, Tibet, China.
Bianba Z; Department of General Surgery, Tibet Autonomous Region People's Hospital, Lhasa, Tibet, China.
Nima Z; Department of Pathology, Tibet Autonomous Region People's Hospital, Lhasa, Tibet, China.
Wang Q; Department of Pathology, Tibet Autonomous Region People's Hospital, Lhasa, Tibet, China.
Wang H; Department of Pathology, Tibet Autonomous Region People's Hospital, Lhasa, Tibet, China.
Liao R; Department of Pathology, Tibet Autonomous Region People's Hospital, Lhasa, Tibet, China.
Ciren Q; Department of Pathology, Tibet Autonomous Region People's Hospital, Lhasa, Tibet, China.
Li M; Department of Pathology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Pang J; Department of Pathology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Pokaż więcej
Źródło :
BioMed research international [Biomed Res Int] 2022 Jun 13; Vol. 2022, pp. 2684065. Date of Electronic Publication: 2022 Jun 13 (Print Publication: 2022).
Typ publikacji :
Journal Article
MeSH Terms :
Epstein-Barr Virus Infections*/complications
Epstein-Barr Virus Infections*/epidemiology
Protein Deficiency*/complications
Stomach Neoplasms*/epidemiology
Stomach Neoplasms*/genetics
Stomach Neoplasms*/metabolism
B7-H1 Antigen/metabolism ; Biomarkers, Tumor/genetics ; Brain Neoplasms ; Colorectal Neoplasms ; DNA Mismatch Repair/genetics ; Herpesvirus 4, Human/genetics ; Herpesvirus 4, Human/metabolism ; Humans ; Immune Checkpoint Inhibitors ; Neoplastic Syndromes, Hereditary ; Prevalence ; Programmed Cell Death 1 Receptor/genetics ; Retrospective Studies ; Tibet/epidemiology ; Tumor Microenvironment/genetics
SCR Disease Name :
Turcot syndrome
Czasopismo naukowe
Tytuł :
Prognosis of incompletely resected small rectal neuroendocrine tumor using endoscope without additional treatment.
Autorzy :
Cha B; Department of Internal Medicine, Digestive Disease Center, Inha University School of Medicine, Inha University Hospital, 27 Inhang-ro, Jung-gu, Incheon, 400-711, Republic of Korea.
Shin J; Department of Internal Medicine, Digestive Disease Center, Inha University School of Medicine, Inha University Hospital, 27 Inhang-ro, Jung-gu, Incheon, 400-711, Republic of Korea.
Ko WJ; Department of Internal Medicine, Digestive Disease Center, Inha University School of Medicine, Inha University Hospital, 27 Inhang-ro, Jung-gu, Incheon, 400-711, Republic of Korea.
Kwon KS; Department of Internal Medicine, Digestive Disease Center, Inha University School of Medicine, Inha University Hospital, 27 Inhang-ro, Jung-gu, Incheon, 400-711, Republic of Korea.
Kim H; Department of Internal Medicine, Digestive Disease Center, Inha University School of Medicine, Inha University Hospital, 27 Inhang-ro, Jung-gu, Incheon, 400-711, Republic of Korea. .
Pokaż więcej
Źródło :
BMC gastroenterology [BMC Gastroenterol] 2022 Jun 09; Vol. 22 (1), pp. 293. Date of Electronic Publication: 2022 Jun 09.
Typ publikacji :
Journal Article
MeSH Terms :
Endoscopic Mucosal Resection*
Neuroendocrine Tumors*/pathology
Neuroendocrine Tumors*/surgery
Rectal Neoplasms*/pathology
Rectal Neoplasms*/surgery
Endoscopes ; Humans ; Intestinal Neoplasms ; Pancreatic Neoplasms ; Prognosis ; Retrospective Studies ; Stomach Neoplasms ; Treatment Outcome
SCR Disease Name :
Gastro-enteropancreatic neuroendocrine tumor
Czasopismo naukowe
Tytuł :
Vaccines for immunoprevention of DNA mismatch repair deficient cancers.
Autorzy :
Hernandez-Sanchez A; Department of Applied Tumor Biology, University Hospital Heidelberg Institute of Pathology, Heidelberg, Germany.
Grossman M; Department of Medicine, Weill Cornell Medicine, New York, New York, USA.
Yeung K; Department of Medicine, Weill Cornell Medicine, New York, New York, USA.
Sei SS; Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland, USA.
Lipkin S; Department of Medicine, Weill Cornell Medicine, New York, New York, USA .
Kloor M; University Hospital Heidelberg, Institute of Pathology, Department of Applied Tumor Biology, Heidelberg, Germany.
Pokaż więcej
Źródło :
Journal for immunotherapy of cancer [J Immunother Cancer] 2022 Jun; Vol. 10 (6).
Typ publikacji :
Journal Article; Review; Research Support, N.I.H., Extramural
MeSH Terms :
Cancer Vaccines*/therapeutic use
Colorectal Neoplasms, Hereditary Nonpolyposis*/genetics
Colorectal Neoplasms, Hereditary Nonpolyposis*/prevention & control
Brain Neoplasms ; Colorectal Neoplasms ; DNA Mismatch Repair ; Humans ; Immunotherapy/methods ; Neoplastic Syndromes, Hereditary
SCR Disease Name :
Turcot syndrome
Czasopismo naukowe
Tytuł :
[Incidental Finding of Appendiceal Neuroendocrine Tumour].
Autorzy :
Thomas M; Klinik für Viszeral-, Allgemeine-, Tumor- und Transplantationschirurgie, Universitätsklinikum Köln, Koln, Deutschland.
Wahba R; Klinik für Viszeral-, Allgemeine-, Tumor- und Transplantationschirurgie, Universitätsklinikum Köln, Koln, Deutschland.
Chiapponi C; Klinik für Viszeral-, Allgemeine-, Tumor- und Transplantationschirurgie, Universitätsklinikum Köln, Koln, Deutschland.
Stippel DL; Klinik für Viszeral-, Allgemeine-, Tumor- und Transplantationschirurgie, Universitätsklinikum Köln, Koln, Deutschland.
Bruns C; Klinik für Viszeral-, Allgemeine-, Tumor- und Transplantationschirurgie, Universitätsklinikum Köln, Koln, Deutschland.
Pokaż więcej
Transliterated Title :
Zufallsbefund NEN Appendix.
Źródło :
Zentralblatt fur Chirurgie [Zentralbl Chir] 2022 Jun; Vol. 147 (3), pp. 244-248. Date of Electronic Publication: 2022 Jun 15.
Typ publikacji :
Journal Article
MeSH Terms :
Appendiceal Neoplasms*/diagnosis
Appendiceal Neoplasms*/pathology
Appendiceal Neoplasms*/surgery
Appendicitis*/diagnosis
Appendicitis*/pathology
Appendicitis*/surgery
Appendix*/pathology
Neuroendocrine Tumors*/diagnosis
Neuroendocrine Tumors*/pathology
Neuroendocrine Tumors*/surgery
Appendectomy ; Humans ; Incidental Findings ; Intestinal Neoplasms ; Pancreatic Neoplasms ; Stomach Neoplasms
SCR Disease Name :
Gastro-enteropancreatic neuroendocrine tumor
Czasopismo naukowe
Tytuł :
Clinicopathological characteristics and survival outcomes of patients with gallbladder neuroendocrine tumor.
Autorzy :
Tan Q; Department of Pancreatic Surgery, West China Hospital, Sichuan University, China.
Wang X; Department of Pancreatic Surgery, West China Hospital, Sichuan University, China.
Li Y; Department of Pancreatic Surgery, West China Hospital, Sichuan University, China.
Tan C; Department of Pancreatic Surgery, West China Hospital, Sichuan University, China. Electronic address: .
Pokaż więcej
Źródło :
Asian journal of surgery [Asian J Surg] 2022 Jun; Vol. 45 (6), pp. 1358-1360. Date of Electronic Publication: 2022 Mar 07.
Typ publikacji :
Letter
MeSH Terms :
Carcinoma, Neuroendocrine*
Gallbladder Neoplasms*/pathology
Gallbladder Neoplasms*/surgery
Neuroendocrine Tumors*/surgery
Humans ; Intestinal Neoplasms ; Pancreatic Neoplasms ; Prognosis ; Stomach Neoplasms
SCR Disease Name :
Gastro-enteropancreatic neuroendocrine tumor
Opinia redakcyjna
Tytuł :
Primary vitreoretinal involvement and immunopositivity for BRAFV600E help distinguish metastatic from primary intraocular melanoma: a detailed histopathologic study of metastatic cutaneous melanoma to the eye.
Autorzy :
Neerukonda VK; David G. Cogan Laboratory of Ophthalmic Pathology, Massachusetts Eye and Ear, Boston, MA, USA.; Department of Ophthalmology, Harvard Medical School, Boston, MA, USA.
Kim IK; Department of Ophthalmology, Harvard Medical School, Boston, MA, USA.; Vitreoretinal Surgery Service, Massachusetts Eye and Ear, Boston, MA, USA.
Stagner AM; David G. Cogan Laboratory of Ophthalmic Pathology, Massachusetts Eye and Ear, Boston, MA, USA.; Department of Ophthalmology, Harvard Medical School, Boston, MA, USA.
Pokaż więcej
Źródło :
Histopathology [Histopathology] 2022 Jun; Vol. 80 (7), pp. 1061-1070. Date of Electronic Publication: 2022 Apr 27.
Typ publikacji :
Journal Article; Observational Study
MeSH Terms :
Eye Neoplasms*/diagnosis
Eye Neoplasms*/genetics
Eye Neoplasms*/secondary
Melanoma*/diagnosis
Melanoma*/genetics
Melanoma*/secondary
Proto-Oncogene Proteins B-raf*/genetics
Skin Neoplasms*/diagnosis
Skin Neoplasms*/genetics
Skin Neoplasms*/pathology
Diagnosis, Differential ; Humans ; Retrospective Studies ; Uveal Neoplasms/diagnosis ; Uveal Neoplasms/genetics ; Uveal Neoplasms/pathology
SCR Disease Name :
Melanoma, Cutaneous Malignant; Uveal melanoma
Czasopismo naukowe
Tytuł :
The HER family as therapeutic targets in colorectal cancer.
Autorzy :
Ye P; Department of Anatomy and Histology, School of Preclinical Medicine, Chengdu University, Chengdu, Sichuan, People's Republic of China. Electronic address: .
Wang Y; School of Preclinical Medicine, Chengdu University, Chengdu, Sichuan, People's Republic of China.
Li R; School of Preclinical Medicine, Chengdu University, Chengdu, Sichuan, People's Republic of China.
Chen W; School of Preclinical Medicine, Chengdu University, Chengdu, Sichuan, People's Republic of China.
Wan L; School of Preclinical Medicine, Chengdu University, Chengdu, Sichuan, People's Republic of China.
Cai P; Department of Anatomy and Histology, School of Preclinical Medicine, Chengdu University, Chengdu, Sichuan, People's Republic of China. Electronic address: .
Pokaż więcej
Źródło :
Critical reviews in oncology/hematology [Crit Rev Oncol Hematol] 2022 Jun; Vol. 174, pp. 103681. Date of Electronic Publication: 2022 Apr 21.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Colorectal Neoplasms*/drug therapy
Colorectal Neoplasms*/genetics
ErbB Receptors*/drug effects
ErbB Receptors*/metabolism
Breast Neoplasms/drug therapy ; Carcinoma, Non-Small-Cell Lung/drug therapy ; Female ; Humans ; Lung Neoplasms ; Receptor, ErbB-2/genetics ; Receptor, ErbB-2/metabolism ; Receptor, ErbB-3/metabolism
Czasopismo naukowe
Tytuł :
The International Association for the Study of Lung Cancer Thymic Epithelial Tumor Staging Project: Unresolved Issues to be Addressed for the Next Ninth Edition of the TNM Classification of Malignant Tumors.
Autorzy :
Ruffini E; University of Torino, Torino, Italy. Electronic address: .
Rami-Porta R; Hospital Universitari Mutua Terrassa, Terrassa, Spain; Network of Centers for Biomedical Research in Respiratory Diseases (CIBERES) Lung Cancer Group, Terrassa, Spain.
Huang J; Memorial Sloan Kettering Cancer Center, New York, New York.
Ahmad U; Cleveland Clinic, Cleveland, Ohio.
Appel S; Sheba Medical Center, Ramat Gan, Israel.
Bille A; Guy's Hospital, London, United Kingdom.
Boubia S; University Hospital Ibn Rochd, Casablanca, Morocco.
Brambilla C; Royal Brompton and Harefield NHS Hospitals, Guy's and St. Thomas' NHS Foundation Trust and National Heart and Lung Institute, Imperial College, London, United Kingdom.
Cangir AK; Ankara University Faculty of Medicine, Ankara, Turkey.
Cilento V; Cancer Research And Biostatistics (CRAB), Seattle, Washington.
Detterbeck F; Yale University School of Medicine, New Haven, Connecticut.
Falkson C; Queen's University in Kingston, Ontario, Canada.
Fang W; Shanghai Chest Hospital, Jiaotong University Medical School, Shanghai, People's Republic of China.
Filosso PL; University of Torino, Torino, Italy.
Giaccone G; Meyer Cancer Center, Weill-Cornell Medicine, New York, New York.
Girard N; Institut Curie, Paris, France.
Guerrera F; University of Torino, Torino, Italy.
Infante M; University and Hospital Trust, Verona, Italy.
Kim DK; Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Lucchi M; Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.
Marino M; IRCCS Regina Elena National Cancer Institute, Rome, Italy.
Marom EM; University of Tel Aviv, the Chaim Sheba Medical Center, Tel Aviv, Israel.
Nicholson AG; Royal Brompton and Harefield NHS Hospitals, Guy's and St. Thomas' NHS Foundation Trust and National Heart and Lung Institute, Imperial College, London, United Kingdom.
Okumura M; National Hospital Organization Osaka Toneyama Medical Center, Osaka, Japan.
Rimner A; Memorial Sloan Kettering Cancer Center, New York, New York.
Simone CB 2nd; Memorial Sloan Kettering Cancer Center, New York, New York.
Asamura H; Keio University, Tokyo, Japan.
Pokaż więcej
Corporate Authors :
IASLC Staging and Prognostic Factors Committee and of the Advisory Boards
Źródło :
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [J Thorac Oncol] 2022 Jun; Vol. 17 (6), pp. 838-851. Date of Electronic Publication: 2022 Mar 20.
Typ publikacji :
Journal Article
MeSH Terms :
Neoplasm Staging*/classification
Neoplasm Staging*/methods
Neoplasms, Glandular and Epithelial*/classification
Neoplasms, Glandular and Epithelial*/pathology
Thymus Neoplasms*/classification
Thymus Neoplasms*/pathology
Humans ; Lung Neoplasms/classification ; Lung Neoplasms/pathology ; Prognosis
SCR Disease Name :
Thymic epithelial tumor
Czasopismo naukowe
Tytuł :
A Phase I Study Investigating AZD8186, a Potent and Selective Inhibitor of PI3Kβ/δ, in Patients with Advanced Solid Tumors.
Autorzy :
Choudhury AD; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
Higano CS; Department of Medical Oncology, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, Washington.
de Bono JS; Drug Development Unit, The Institute of Cancer Research and Royal Marsden, London, United Kingdom.
Cook N; The Christie NHS Foundation Trust and The University of Manchester, Manchester, United Kingdom.
Rathkopf DE; Memorial Sloan Kettering Cancer Center and Weill Cornell Medicine, New York, New York.
Wisinski KB; Carbone Cancer Center, University of Wisconsin-Madison, Madison, Wisconsin.
Martin-Liberal J; Medical Oncology Department, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Barcelona, Spain.
Linch M; University College London (UCL) Cancer Institute and UCL Hospital, London, United Kingdom.
Heath EI; Department of Oncology, Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Michigan.
Baird RD; Cancer Research UK Cambridge Center, Cambridge, United Kingdom.
García-Carbacho J; Department of Medical Oncology (Hospital Clinic Barcelona)/Translational Genomics and Targeted Therapies in Solid Tumors (IDIBAPS), Barcelona, Spain.
Quintela-Fandino M; Hospital Universitario, Quiron Madrid, Madrid, Spain.
Barry ST; Oncology R&D, AstraZeneca, Cambridge, United Kingdom.
de Bruin EC; Oncology R&D, AstraZeneca, Cambridge, United Kingdom.
Colebrook S; Oncology R&D, AstraZeneca, Cambridge, United Kingdom.
Hawkins G; Oncology R&D, AstraZeneca, Cambridge, United Kingdom.
Klinowska T; Oncology R&D, AstraZeneca, Cambridge, United Kingdom.
Maroj B; Oncology R&D, AstraZeneca, Cambridge, United Kingdom.
Moorthy G; Clinical Pharmacology & Quantitative Pharmacology (CPQP), Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Boston, Massachusetts.
Mortimer PG; Oncology R&D, AstraZeneca, Cambridge, United Kingdom.
Moschetta M; Oncology R&D, AstraZeneca, Cambridge, United Kingdom.
Nikolaou M; Oncology R&D, AstraZeneca, Cambridge, United Kingdom.
Sainsbury L; Oncology R&D, AstraZeneca, Cambridge, United Kingdom.
Shapiro GI; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
Siu LL; Division of Medical Oncology and Hematology, Princess Margaret Cancer Center, University Health Network, University of Toronto, Toronto, Ontario, Canada.; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
Hansen AR; Division of Medical Oncology and Hematology, Princess Margaret Cancer Center, University Health Network, University of Toronto, Toronto, Ontario, Canada.; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
Pokaż więcej
Źródło :
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2022 Jun 01; Vol. 28 (11), pp. 2257-2269.
Typ publikacji :
Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Aniline Compounds*/adverse effects
Chromones*/adverse effects
Neoplasms*/drug therapy
Neoplasms*/pathology
Abiraterone Acetate/therapeutic use ; Carcinoma, Non-Small-Cell Lung/drug therapy ; Carcinoma, Non-Small-Cell Lung/etiology ; Humans ; Lung Neoplasms/drug therapy ; Male ; Prednisone/therapeutic use ; Prostate-Specific Antigen ; Prostatic Neoplasms/drug therapy
Czasopismo naukowe
Tytuł :
Mortality and Second Cancer Incidence After Treatment for Testicular Cancer: Psychosocial Health and Lifestyle Are Modifiable Prognostic Factors.
Autorzy :
Fosså SD; Department of Oncology, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Dahl AA; Department of Oncology, Oslo University Hospital, Oslo, Norway.
Thorsen L; Department of Clinical Service, Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway.
Hellesnes R; Department of Oncology, University Hospital of North Norway, Tromsø, Norway.
Kiserud CE; Department of Oncology, Oslo University Hospital, Oslo, Norway.
Tandstad T; The Cancer Clinic, St Olavs University Hospital, Trondheim Norway.; Department of Clinical and Molecular Medicine, The Norwegian University of Science and Technology, Trondheim, Norway.
Brydøy M; Department of Oncology, Haukeland University Hospital, Bergen, Norway.
Haugnes HS; Department of Oncology, University Hospital of North Norway, Tromsø, Norway.; Department of Clinical Medicine, UiT, The Arctic University, Tromsø, Norway.
Myklebust TÅ; Department of Research and Innovation, Møre and Romsdal Hospital Trust, Ålesund, Norway.; Department of Registration, Cancer Registry of Norway, Oslo, Norway.
Pokaż więcej
Źródło :
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2022 Aug 10; Vol. 40 (23), pp. 2588-2599. Date of Electronic Publication: 2022 Apr 05.
Typ publikacji :
Journal Article
MeSH Terms :
Neoplasms, Second Primary*/chemically induced
Testicular Neoplasms*/drug therapy
Cisplatin ; Humans ; Incidence ; Life Style ; Male ; Neoplasms, Germ Cell and Embryonal ; Prognosis
SCR Disease Name :
Testicular Germ Cell Tumor
Czasopismo naukowe
Tytuł :
The lung fibroblast as "soil fertilizer" in breast cancer metastasis.
Autorzy :
Houthuijzen JM; Division of Molecular Pathology, Oncode Institute, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands. Electronic address: .
de Visser KE; Division of Tumor Biology & Immunology, Oncode Institute, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands; Department of Immunology, Leiden University Medical Center, Leiden, the Netherlands. Electronic address: .
Pokaż więcej
Źródło :
Immunity [Immunity] 2022 Aug 09; Vol. 55 (8), pp. 1336-1339.
Typ publikacji :
Journal Article
MeSH Terms :
Breast Neoplasms*
Lung Neoplasms*/pathology
Cell Line, Tumor ; Female ; Fertilizers ; Fibroblasts/pathology ; Humans ; Lung/pathology ; Melanoma ; Neoplasm Metastasis/pathology ; Skin Neoplasms ; Soil ; Tumor Microenvironment
SCR Disease Name :
Melanoma, Cutaneous Malignant
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies